When.com Web Search

  1. Ads

    related to: examples of substrate feeders for dogs with arthritis treatment cost

Search results

  1. Results From The WOW.Com Content Network
  2. Polysulfated glycosaminoglycan - Wikipedia

    en.wikipedia.org/wiki/Polysulfated_glycosaminoglycan

    PSGAG is mostly used in dogs and horses for treating traumatic arthritis and degenerative joint disease (osteoarthritis). [7] It has shown to be better at treating acute than chronic arthritis , though some studies say that its effectiveness in acute cases is still limited if degenerative enzymes have not played a role. [ 8 ]

  3. Vet-Approved Home Treatment for Senior Dogs with Arthritis - AOL

    www.aol.com/lifestyle/vet-approved-home...

    An exam would not cost much, but she will probably also need x-rays and blood tests, and in some cases, dogs need a CT exam or a spinal tap. If you can afford surgery, a disease like IVDD can be ...

  4. Bedinvetmab - Wikipedia

    en.wikipedia.org/wiki/Bedinvetmab

    Half the dogs received bedinvetmab and half the dogs received a sterile saline injection every 28 days for a total of three doses. [5] Before treatment and on various days throughout the study, owners used the Canine Brief Pain Inventory (CBPI) assessment tool to measure the severity of the dog's pain and the degree to which the pain interfered ...

  5. Enzyme replacement therapy - Wikipedia

    en.wikipedia.org/wiki/Enzyme_replacement_therapy

    Substrate reduction therapy uses a small molecule to interrupt this multi-step pathway and inhibit the biosynthesis of these compounds. [10] This type of treatment is taken orally. [ 10 ] It does not induce an unwanted immune response, and a single type of small molecule could be used to treat many lysosomal storage diseases. [ 10 ]

  6. P-glycoprotein - Wikipedia

    en.wikipedia.org/wiki/P-glycoprotein

    P-gp is a 170 kDa transmembrane glycoprotein, which includes 10–15 kDa of N-terminal glycosylation.The N-terminal half of the protein contains six transmembrane helixes, followed by a large cytoplasmic domain with an ATP-binding site, and then a second section with six transmembrane helixes and an ATP-binding domain that shows over 65% of amino acid similarity with the first half of the ...

  7. Substrate reduction therapy - Wikipedia

    en.wikipedia.org/wiki/Substrate_reduction_therapy

    Substrate reduction therapy offers an approach to treatment of certain metabolic disorders, especially glycogen storage diseases and lysosomal storage disorders. In a storage disorder, a critical failure in a metabolic pathway prevents cellular breakdown and disposal of some large molecule. If residual breakdown through other pathways is ...